Ra Medical Systems Inc (RMED):企業の製品パイプライン分析

◆英語タイトル:Ra Medical Systems Inc (RMED) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME206630PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ra Medical Systems Inc (Ra Medical Systems) is a medical device company that develops, designs, and commercializes excimer laser systems for the treatment of cardiovascular and dermatologic diseases. The company’s technology provides operational versatility and dose customization. Its products portfolio include dabra system a versatile catheter and excimer laser system for the treatment of complex and diffuse arterial blockages in the lower vessels. It also provides pharos a monochromatic, xenon-chlorine, and 308-nm UVB excimer laser for the treatment of chronic diseases such as vitiligo and psoriasis. Ra Medical System’s pharos excimer laser is designed for clinical, physician’s, and business requirements. The company has its operations in San Diego, California and Los Angeles, the US. Ra Medical Systems is headquartered in Carlsbad, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Ra Medical Systems Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Ra Medical Systems Inc Company Overview
Ra Medical Systems Inc Company Snapshot
Ra Medical Systems Inc Pipeline Products and Ongoing Clinical Trials Overview
Ra Medical Systems Inc – Pipeline Analysis Overview
Ra Medical Systems Inc – Key Facts
Ra Medical Systems Inc – Major Products and Services
Ra Medical Systems Inc Pipeline Products by Development Stage
Ra Medical Systems Inc Ongoing Clinical Trials by Trial Status
Ra Medical Systems Inc Pipeline Products Overview
DABRA – Atherectomy
DABRA – Atherectomy Product Overview
DABRA – Atherectomy Clinical Trial
DABRA – Coronary Artery Disease
DABRA – Coronary Artery Disease Product Overview
DABRA – In-Stent Restenosis
DABRA – In-Stent Restenosis Product Overview
PHAROS – Cutaneous T-Cell Lymphoma
PHAROS – Cutaneous T-Cell Lymphoma Product Overview
Ra Medical Systems Inc – Key Competitors
Ra Medical Systems Inc – Key Employees
Ra Medical Systems Inc – Locations And Subsidiaries
Head Office
Recent Developments
Ra Medical Systems Inc, Recent Developments
Feb 28, 2020: Ra Medical System enrols first patient for atherectomy clinical trial
Jan 23, 2020: Ra Medical Systems to showcase Pharos, Optimized Dermatology Excimer Laser at two upcoming dermatology conferences
Jan 22, 2020: Ra Medical Systems gets IDE approval for DABRA system
Jan 07, 2020: Ra Medical Systems names Dr. Chris Folk Vice President of Engineering
Nov 29, 2019: Ra Medical Systems reports third quarter 2019 financial results
Oct 31, 2019: Ra Medical Systems announces substantial completion of Audit Committee Investigation
Sep 27, 2019: Ra Medical Systems announces recall of DABRA laser system
Aug 12, 2019: Ra Medical Systems reports preliminary second quarter 2019 financial results
Jul 29, 2019: Ra Medical Systems introduces new dermatology excimer laser
Jun 21, 2019: Expert Panel to demonstrate DABRA clinical outcomes vil live cases and symposium at C3
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Ra Medical Systems Inc Pipeline Products and Ongoing Clinical Trials Overview
Ra Medical Systems Inc Pipeline Products by Equipment Type
Ra Medical Systems Inc Pipeline Products by Indication
Ra Medical Systems Inc Ongoing Clinical Trials by Trial Status
Ra Medical Systems Inc, Key Facts
Ra Medical Systems Inc, Major Products and Services
Ra Medical Systems Inc Number of Pipeline Products by Development Stage
Ra Medical Systems Inc Pipeline Products Summary by Development Stage
Ra Medical Systems Inc Ongoing Clinical Trials by Trial Status
Ra Medical Systems Inc Ongoing Clinical Trials Summary
DABRA - Atherectomy - Product Status
DABRA - Atherectomy - Product Description
DABRA - Atherectomy - A Prospective, Multicenter Atherectomy Study Showing Luminal Gain in Subjects with Peripheral Vascular Blockages
DABRA - Coronary Artery Disease - Product Status
DABRA - Coronary Artery Disease - Product Description
DABRA - In-Stent Restenosis - Product Status
DABRA - In-Stent Restenosis - Product Description
PHAROS - Cutaneous T-Cell Lymphoma - Product Status
PHAROS - Cutaneous T-Cell Lymphoma - Product Description
Ra Medical Systems Inc, Key Employees
Glossary

★海外企業調査レポート[Ra Medical Systems Inc (RMED):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orpea SA (ORP):企業の財務・戦略的SWOT分析
    Summary Orpea SA (Orpea) is a healthcare consulting company that offers clinical care services. The company provides services such as suite care clinic services, retirement homes, and mental hospital services, among others. Its mental hospital services include treatment of mood disorders, overuse sy …
  • Eagle Pharmaceuticals Inc (EGRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Eagle Pharmaceuticals Inc (Eagle Pharma) is a specialty pharmaceutical company that offers proprietary pharmaceutical injectables in the therapy areas of critical care, oncology, and various orphan diseases. The company’s commercial product portfolio encompasses pharmaceutical injectables, i …
  • Silver Bull Resources, Inc.:企業の戦略・SWOT・財務情報
    Silver Bull Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Silver Bull Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Eftec AG:企業の戦略的SWOT分析
    Eftec AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • TECT Aerospace, Inc.:企業の戦略・SWOT・財務情報
    TECT Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report Summary TECT Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Clean TeQ Holdings Ltd (CLQ):企業の財務・戦略的SWOT分析
    Summary Clean TeQ Holdings Ltd (Clean TeQ) is a clean technology company that offers air pollution control solutions using biotechnology-based processes. The company provides water treatment products such as advanced separations, advanced oxidation, encapsulated bacteria, continuous ionic filtration …
  • Healx Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Healx Ltd (Healx) is a provider of drug repurposing solutions and combinational medicines for advancing the treatment of rare diseases. The company’s technology combines biological data analysis with advanced machine learning algorithms to identify novel drug applications for rare diseases. …
  • Melrose Industries PLC (MRO):企業の財務・戦略的SWOT分析
    Summary Melrose Industries PLC (Melrose) is an investment company that improve and sell industrial and manufacturing businesses. The company offers products such as air management, security, home automation and ergonomic and electricity generating equipment. Its business portfolio comprises of Norte …
  • StemCells, Inc.:企業のM&A・事業提携・投資動向
    StemCells, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's StemCells, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Shine Medical Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Shine Medical Technologies Inc (Shine Medical) is a manufacturer and supplier of medical tracers and cancer treatment elements. The company’s products include molybdenum-99 is the parent isotope of technetium 99m for diagnosing and staging multitude of diseases, including cancer and heart di …
  • Mithra Pharmaceuticals SA (MITRA):企業の財務・戦略的SWOT分析
    Summary Mithra Pharmaceuticals SA (Mithra) develops and manufactures over the counter products for women’s health and other applications. The company offers various drug products such as donesta, estelle, tibelia, myring, and zoreline. Its products are used in the treatment of contraception and fert …
  • Vitol Group:企業の戦略・SWOT・財務情報
    Vitol Group - Strategy, SWOT and Corporate Finance Report Summary Vitol Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Lexmark International Inc:企業の戦略的SWOT分析
    Lexmark International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Li Ning Company Ltd (2331):企業の財務・戦略的SWOT分析
    Li Ning Company Ltd (2331) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • BTG Plc (BTG):製薬・医療:M&Aディール及び事業提携情報
    Summary BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for …
  • Lafarge Malaysia Berhad (LAFMSIA):企業の財務・戦略的SWOT分析
    Summary Lafarge Malaysia Berhad (LMB), formerly Lafarge Malayan Cement Berhad is a construction company that manufactures and markets aggregates, ready-mixed concrete, cement, and related construction and building materials. The company offers cement products such as walcrete, rumah, phoenix, oil we …
  • Centric Health Corporation:企業のM&A・事業提携・投資動向
    Centric Health Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Centric Health Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Saniona AB (SANION):企業の財務・戦略的SWOT分析
    Summary Saniona AB (Saniona), formerly Aniona is a research and development company that develops drugs for central nervous system diseases, autoimmune diseases, metabolic diseases and pain management. The company’s pipeline products include tesofensine, a triple monoamine reuptake inhibitor, which …
  • UniCredit S.p.A:企業のM&A・事業提携・投資動向
    UniCredit S.p.A - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's UniCredit S.p.A Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • KEC International Ltd:企業の戦略・SWOT・財務情報
    KEC International Ltd - Strategy, SWOT and Corporate Finance Report Summary KEC International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆